Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

KURA – Kura Oncology, Inc.

KURA — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

15.97

Margin Of Safety %

Put/Call OI Ratio

0.79

EPS Next Q Diff

-0.06

EPS Last/This Y

-0.26

EPS This/Next Y

0.86

Price

9.58

Target Price

31.17

Analyst Recom

1.2

Performance Q

Upside

-555.1%

Beta

0.39

Ticker: KURA




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13KURA10.90.210.6010063
2026-07-14KURA11.230.220.7210166
2026-07-15KURA11.340.231.5410258
2026-07-16KURA10.890.221.0110213
2026-07-17KURA10.850.241.509972
2026-07-20KURA10.670.581.153533
2026-07-21KURA10.880.570.634219
2026-07-22KURA10.530.520.134852
2026-07-23KURA10.440.4578.335487
2026-07-24KURA10.390.4821.645613
2026-07-27KURA10.150.490.005651
2026-07-28KURA9.30.474.995647
2026-07-29KURA8.930.630.336485
2026-07-30KURA9.310.625.276614
2026-07-31KURA9.020.6413.616683
2026-08-03KURA9.180.781.787418
2026-08-04KURA9.470.781.247492
2026-08-05KURA9.20.762.607914
2026-08-06KURA9.280.791.288162
2026-08-07KURA9.570.791.228271
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13KURA10.91-18.1-13.5-3.46
2026-07-14KURA11.23-18.1-72.7-3.46
2026-07-15KURA11.34-18.1-54.4-3.46
2026-07-16KURA10.89-18.1-18.2-3.46
2026-07-17KURA10.86-18.1-47.0-3.46
2026-07-20KURA10.68-18.1-34.7-3.46
2026-07-21KURA10.89-18.1-65.0-3.46
2026-07-22KURA10.53-18.1-21.4-3.46
2026-07-23KURA10.44-18.1-40.7-3.46
2026-07-24KURA10.40-16.7-43.5-3.44
2026-07-27KURA10.13-16.7-26.7-3.44
2026-07-28KURA9.30-16.727.3-3.44
2026-07-29KURA8.92-16.7-5.3-3.44
2026-07-30KURA9.32-16.7-99.0-3.44
2026-07-31KURA9.01-16.7-14.5-3.44
2026-08-03KURA9.19-16.7-68.3-3.44
2026-08-04KURA9.19-16.7-68.3-3.44
2026-08-05KURA9.20-16.7-20.2-3.44
2026-08-06KURA9.29-16.7-58.3-3.44
2026-08-07KURA9.58-16.7-80.6-3.44
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13KURA-4.66-0.6017.55
2026-07-14KURA-4.66-0.6017.55
2026-07-15KURA-4.66-0.6017.55
2026-07-16KURA-4.66-0.6017.55
2026-07-17KURA-4.66-0.6017.55
2026-07-20KURA-4.66-0.3617.55
2026-07-21KURA-4.66-0.3617.55
2026-07-22KURA-4.66-0.3617.55
2026-07-23KURA-4.66-0.3617.55
2026-07-24KURA-4.66-0.3617.55
2026-07-27KURA-4.66-0.3215.97
2026-07-28KURA-3.47-0.3215.97
2026-07-29KURA-3.47-0.3215.97
2026-07-30KURA-3.47-0.3215.97
2026-07-31KURA-3.47-0.3215.97
2026-08-03KURA-3.47-0.0315.97
2026-08-04KURA-3.47-0.0315.97
2026-08-06KURA-3.47-0.0315.97
2026-08-07KURA-3.47-0.0315.97
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

-0.83

Avg. EPS Est. Current Quarter

-0.88

Avg. EPS Est. Next Quarter

-0.89

Insider Transactions

-3.47

Institutional Transactions

-0.03

Beta

0.39

Average Sales Estimate Current Quarter

20

Average Sales Estimate Next Quarter

23

Fair Value

Quality Score

37

Growth Score

24

Sentiment Score

37

Actual DrawDown %

60.4

Max Drawdown 5-Year %

-76.5

Target Price

31.17

P/E

Forward P/E

PEG

P/S

11.86

P/B

7.87

P/Free Cash Flow

EPS

-3.35

Average EPS Est. Cur. Y​

-3.44

EPS Next Y. (Est.)

-2.58

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-411.19

Relative Volume

0.43

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

-80.6
KURA Healthcare
$9.57
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
17/25
Volume
11/15
Valuation
10/20
TP/AR
2/10
Options
3/10
RSI
44.5
Range 1M
21.8%
Sup Dist
4.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
11 /100
WEAK
Momentum
1/25
Growth
5/30
Estimates
0/20
Inst/Vol
0/15
Options
5/10
EPS Yr
-9.7%
52W%
58.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +225.7% upside
Quality
6/30
Valuation
16/30
Growth
2/25
Stability
7/10
LT Trend
0/5
Upside
+225.7%
Quality
37
KURA — P/E HistoricalBiotechnology
Kura Oncology, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
KURA

Latest News

Caricamento notizie per KURA
stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today
news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance
stock history KURA – Kura Oncology, Inc. invest stock market
stock prices KURA premarket after hours
ticker KURA fair value insiders trading